Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: Among immunocompromised patients with acute respiratory failure, identification of those at higher risk for opportunistic infections is crucial to optimize management. The Torque teno virus (TTV) DNA burden in the blood has been identified as a surrogate marker of functional immunity in solid organ transplant recipients. This study investigates the clinical relevance of TTV DNA in nasopharyngeal swabs of immunocompromised patients with acute respiratory failure (ARF).

Methods: We enrolled immunocompromised patients with acute respiratory failure admitted to 32 ICUs. Nasopharyngeal swabs collected on admission were tested for TTV DNA. Causes of ARF were reviewed by three expert investigators blinded to TTV results, with a specific attention to the presence of opportunistic infections. The primary endpoint was the association between TTV DNA burden in nasopharyngeal swabs and the rate of opportunistic infections causing the ARF.

Results: Of the 505 patients, respiratory TTV DNA was detected in 304/505 (60%), with TTV burden≥2.9 logcopies/mL in 184/305 (36%). TTV burden≥2.9 logcopies/mL was significantly associated with a higher prevalence of opportunistic infections (20% (36/178) vs. 11% (33/307), adjusted OR 2.41, 95%CI 1.35 to 4.28; p=0.002). High TTV burden ≥2.9 logcopies/mL was also associated with a higher rate of all-cause pulmonary infections (67% (119/178) vs. 56% (108/192) when not detected), microbiologically documented bacterial infections (35% (62/178) vs. 23% (45/192)), and with a higher rate of Influenza-like respiratory virus detection in nasopharyngeal swabs (15% (27/184) vs. 6% (12/201) when not detected). Furthermore, TTV detection was associated with a higher rate of mechanical ventilation or death at day 28 (59% (179/304) vs. 48% (97/201) when not detected).

Conclusions: In immunocompromised patients with acute respiratory failure, high TTV burden in the respiratory tract is associated with higher rates of pulmonary infections due to opportunistic pathogens and with adverse outcomes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cmi.2025.07.035DOI Listing

Publication Analysis

Top Keywords

immunocompromised patients
20
patients acute
20
acute respiratory
20
respiratory failure
20
ttv dna
20
opportunistic infections
16
nasopharyngeal swabs
16
associated higher
16
higher rate
12
ttv
11

Similar Publications

Microbial cell-free DNA for diagnosis of bacterial and fungal infection in the immunocompromised host - what do we know?

Curr Opin Infect Dis

August 2025

Transplant and Immunocompromised Host Infectious Diseases, Department of Medicine, Infectious Diseases Division, Massachusetts General Hospital.

Purpose Of Review: Plasma metagenomic next-generation sequencing (mNGS) enables detection of microbial cell-free deoxyribonucleic acid (mcfDNA) in blood without the need for culture or organism-specific primers. Here, we review clinical performance, methodological variability, and real-world application of plasma mNGS for infectious disease diagnosis in immunocompromised hosts (ICHs).

Recent Findings: Plasma mNGS has rapidly gained attention as a novel diagnostic tool for infections in ICHs, offering broad-range pathogen detection from a noninvasive blood sample.

View Article and Find Full Text PDF

Unlabelled: Accurate methods to assess viral viability are crucial for determining isolation duration and antiviral therapy in immunocompromised patients. Although cell culture (CC) is the gold standard, it has limitations. Cycle threshold (Ct) values from genomic RNA (gRNA) RT-PCR and subgenomic RNA (sgRNA) RT-PCR have been proposed as markers of active viral replication.

View Article and Find Full Text PDF

Introduction: Acute severe ulcerative colitis (ASUC) typically requires hospitalization for intravenous (IV) corticosteroid treatment and monitoring. In response to the need to reduce inpatient stays, especially during the COVID-19 pandemic, outpatient treatment models have gained interest. This study evaluated the feasibility, safety, and patient satisfaction of outpatient IV corticosteroid treatment for ASUC.

View Article and Find Full Text PDF

, an opportunistic protozoan parasite, poses significant risks to immunocompromised patients, including those with cancer, transplants, or on hemodialysis. The aim of this study was to determine the pooled prevalence of in immunocompromised individuals (cancer, transplant, and hemodialysis) and assess the associated risk factors compared to nonimmunocompromised controls. A comprehensive search of international databases was conducted for studies published up to October 18, 2024, focusing on cross-sectional and case-control studies that reported prevalence in immunocompromised patients.

View Article and Find Full Text PDF